These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 18725385

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. p130Cas is required for mammary tumor growth and transforming growth factor-beta-mediated metastasis through regulation of Smad2/3 activity.
    Wendt MK, Smith JA, Schiemann WP.
    J Biol Chem; 2009 Dec 04; 284(49):34145-56. PubMed ID: 19822523
    [Abstract] [Full Text] [Related]

  • 4. Lysyl oxidase contributes to mechanotransduction-mediated regulation of transforming growth factor-β signaling in breast cancer cells.
    Taylor MA, Amin JD, Kirschmann DA, Schiemann WP.
    Neoplasia; 2011 May 04; 13(5):406-18. PubMed ID: 21532881
    [Abstract] [Full Text] [Related]

  • 5. Fibulin-5 initiates epithelial-mesenchymal transition (EMT) and enhances EMT induced by TGF-beta in mammary epithelial cells via a MMP-dependent mechanism.
    Lee YH, Albig AR, Regner M, Schiemann BJ, Schiemann WP.
    Carcinogenesis; 2008 Dec 04; 29(12):2243-51. PubMed ID: 18713838
    [Abstract] [Full Text] [Related]

  • 6. Beta3 integrin and Src facilitate transforming growth factor-beta mediated induction of epithelial-mesenchymal transition in mammary epithelial cells.
    Galliher AJ, Schiemann WP.
    Breast Cancer Res; 2006 Dec 04; 8(4):R42. PubMed ID: 16859511
    [Abstract] [Full Text] [Related]

  • 7. The use of cystatin C to inhibit epithelial-mesenchymal transition and morphological transformation stimulated by transforming growth factor-beta.
    Sokol JP, Neil JR, Schiemann BJ, Schiemann WP.
    Breast Cancer Res; 2005 Dec 04; 7(5):R844-53. PubMed ID: 16168131
    [Abstract] [Full Text] [Related]

  • 8. Src phosphorylates Tyr284 in TGF-beta type II receptor and regulates TGF-beta stimulation of p38 MAPK during breast cancer cell proliferation and invasion.
    Galliher AJ, Schiemann WP.
    Cancer Res; 2007 Apr 15; 67(8):3752-8. PubMed ID: 17440088
    [Abstract] [Full Text] [Related]

  • 9. Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-beta signaling and metastasis.
    Wendt MK, Schiemann WP.
    Breast Cancer Res; 2009 Apr 15; 11(5):R68. PubMed ID: 19740433
    [Abstract] [Full Text] [Related]

  • 10. The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells.
    Taylor MA, Parvani JG, Schiemann WP.
    J Mammary Gland Biol Neoplasia; 2010 Jun 15; 15(2):169-90. PubMed ID: 20467795
    [Abstract] [Full Text] [Related]

  • 11. Effects of all-trans retinoic acid on signal pathway of cyclooxygenase-2 and Smad3 in transforming growth factor-β-stimulated glomerular mesangial cells.
    Han J, Zhang L, Chen X, Yang B, Guo N, Fan Y.
    Exp Biol Med (Maywood); 2014 Mar 15; 239(3):272-83. PubMed ID: 24500985
    [Abstract] [Full Text] [Related]

  • 12. Smad anchor for receptor activation (SARA) in TGF-beta signaling.
    Tang WB, Ling GH, Sun L, Liu FY.
    Front Biosci (Elite Ed); 2010 Jun 01; 2(3):857-60. PubMed ID: 20515759
    [Abstract] [Full Text] [Related]

  • 13. Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells.
    Zhang J, Thorikay M, van der Zon G, van Dinther M, Ten Dijke P.
    J Vis Exp; 2020 Oct 27; (164):. PubMed ID: 33191940
    [Abstract] [Full Text] [Related]

  • 14. TGF-β1 stimulates cyclooxygenase-2 expression and PGE2 production of human dental pulp cells: Role of ALK5/Smad2 and MEK/ERK signal transduction pathways.
    Lin PS, Cheng RH, Chang MC, Lee JJ, Chang HH, Huang WL, Yeung SY, Chang YC, Jeng JH.
    J Formos Med Assoc; 2017 Oct 27; 116(10):748-754. PubMed ID: 28779848
    [Abstract] [Full Text] [Related]

  • 15. Vasohibin-2 is required for epithelial-mesenchymal transition of ovarian cancer cells by modulating transforming growth factor-β signaling.
    Norita R, Suzuki Y, Furutani Y, Takahashi K, Yoshimatsu Y, Podyma-Inoue KA, Watabe T, Sato Y.
    Cancer Sci; 2017 Mar 27; 108(3):419-426. PubMed ID: 28064471
    [Abstract] [Full Text] [Related]

  • 16. Smad2 and Smad3 phosphorylated at both linker and COOH-terminal regions transmit malignant TGF-beta signal in later stages of human colorectal cancer.
    Matsuzaki K, Kitano C, Murata M, Sekimoto G, Yoshida K, Uemura Y, Seki T, Taketani S, Fujisawa J, Okazaki K.
    Cancer Res; 2009 Jul 01; 69(13):5321-30. PubMed ID: 19531654
    [Abstract] [Full Text] [Related]

  • 17. Smad2/3/4 Pathway Contributes to TGF-β-Induced MiRNA-181b Expression to Promote Gastric Cancer Metastasis by Targeting Timp3.
    Zhou Q, Zheng X, Chen L, Xu B, Yang X, Jiang J, Wu C.
    Cell Physiol Biochem; 2016 Jul 01; 39(2):453-66. PubMed ID: 27383203
    [Abstract] [Full Text] [Related]

  • 18. ShcA Protects against Epithelial-Mesenchymal Transition through Compartmentalized Inhibition of TGF-β-Induced Smad Activation.
    Muthusamy BP, Budi EH, Katsuno Y, Lee MK, Smith SM, Mirza AM, Akhurst RJ, Derynck R.
    PLoS Biol; 2015 Dec 01; 13(12):e1002325. PubMed ID: 26680585
    [Abstract] [Full Text] [Related]

  • 19. EGF induces epithelial-mesenchymal transition through phospho-Smad2/3-Snail signaling pathway in breast cancer cells.
    Kim J, Kong J, Chang H, Kim H, Kim A.
    Oncotarget; 2016 Dec 20; 7(51):85021-85032. PubMed ID: 27829223
    [Abstract] [Full Text] [Related]

  • 20. Deletion of Smad2 in mouse liver reveals novel functions in hepatocyte growth and differentiation.
    Ju W, Ogawa A, Heyer J, Nierhof D, Yu L, Kucherlapati R, Shafritz DA, Böttinger EP.
    Mol Cell Biol; 2006 Jan 20; 26(2):654-67. PubMed ID: 16382155
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.